empagliflozin glp-1 SGLT2i and RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study | Diabetologia Two target trial emulation studies
Pay in 4 interest-free payments of $5.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


























